Highlight article: The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer

被引:33
作者
Hryniewicz-Jankowska, Anita [1 ]
Augoff, Katarzyna [2 ]
Sikorski, Aleksander F. [1 ]
机构
[1] Univ Wroclaw, Fac Biotechnol, Dept Cytobiochem, PL-50383 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Surg Educ, PL-50369 Wroclaw, Poland
关键词
Cholesterol; membrane raft domains; caveolae; signaling pathways; prostate cancer; RICH LIPID RAFTS; GROWTH-FACTOR; NEUROENDOCRINE DIFFERENTIATION; HIGH-GRADE; EXPRESSION; RECEPTOR; CELLS; ACTIVATION; AKT; SURVIVAL;
D O I
10.1177/1535370219870771
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Membrane rafts are heterogeneous and dynamic domains that are characterized by tight packing of lipids. They are enriched in cholesterol, sphingolipids, and certain types of proteins. Among these are various cell signaling proteins, which indicate that rafts play an important role in cell signal transduction pathways, including some involved in cancer development, progression, and invasiveness. Due to their increased cholesterol content, raft domains exhibit lower fluidity than the surrounding membrane. The cell membranes of some solid tumors, such as breast and prostate cancer, contain higher levels of cholesterol, which means larger raft domain can form in those membranes. This may stimulate signaling pathways to promote tumor growth and progression. This review focuses on the known raft-dependent regulatory mechanisms that promote prostate cancer progression. Impact statement Prostate cancer remains the most common malignancy and second most frequent cause of cancer-related death in men. Cholesterol levels are usually higher in prostate cancer cells. This affects the cell membrane composition, with cholesterol and sphingolipid-containing raft membrane domains becoming a greater component. In addition to polar lipids, these domains recruit and regulate certain types of protein, including various cell signaling proteins that are critical to cancer cell survival and invasiveness. This suggests that membrane rafts have a regulatory role in tumor progression, making them a potential target in prostate cancer treatment.
引用
收藏
页码:1053 / 1061
页数:9
相关论文
共 79 条
[1]   Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer [J].
Akashi, Takuya ;
Koizumi, Keiichi ;
Tsuneyama, Koichi ;
Saiki, Ikuo ;
Takano, Yasuo ;
Fuse, Hideki .
CANCER SCIENCE, 2008, 99 (03) :539-542
[2]  
Badawi Alaa F., 2007, V10, P87
[3]   Connecting mTORC1 signaling to SREBP-1 activation [J].
Bakan, Inan ;
Laplante, Mathieu .
CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (03) :226-234
[4]   Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation [J].
Bonacina, Fabrizia ;
Coe, David ;
Wang, Guosu ;
Longhi, Maria P. ;
Baragetti, Andrea ;
Moregola, Annalisa ;
Garlaschelli, Katia ;
Uboldi, Patrizia ;
Pellegatta, Fabio ;
Grigore, Liliana ;
Da Dalt, Lorenzo ;
Annoni, Andrea ;
Gregori, Silvia ;
Xiao, Qingzhong ;
Caruso, Donatella ;
Mitro, Nico ;
Catapano, Alberico L. ;
Marelli-Berg, Federica M. ;
Norata, Giuseppe D. .
NATURE COMMUNICATIONS, 2018, 9
[5]   The SPFH domain-containing proteins: more than lipid raft markers [J].
Browman, Duncan T. ;
Hoegg, Maja B. ;
Robbins, Stephen M. .
TRENDS IN CELL BIOLOGY, 2007, 17 (08) :394-402
[6]   Structure and function of sphingolipid- and cholesterol-rich membrane rafts [J].
Brown, DA ;
London, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) :17221-17224
[7]   The HIV lipidome:: A raft with an unusual composition [J].
Brügger, B ;
Glass, B ;
Haberkant, P ;
Leibrecht, I ;
Wieland, FT ;
Kräusslich, HG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (08) :2641-2646
[8]  
Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO
[9]  
2-2
[10]   The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction [J].
Cheng, Jinrong ;
Wu, Yue ;
Mohler, James L. ;
Ip, Clement .
CANCER BIOLOGY & THERAPY, 2010, 9 (12) :1033-1042